| |
Arthritis News Archive13-Nov-2006
Actemra? Has A Major Impact On Improving Remission Rates In Rheumatoid Arthritis - 3 Studies From The Japanese Phase (Medical News Today)
On the 13th November 2006, impressive results will be presented at ACR, the American College of Rheumatology, Washington D. C. These data highlight the outstanding symptom control with Actemra (tocilizumab) monotherapy for patients with rheumatoid arthritis (RA). [click link for full article]
Rheumatoid Arthritis Patients Receiving Anti-TNF Therapy Can Be Effectively Immunized (Medical News Today)
Despite being immunosuppressed, patients with rheumatoid arthritis are able to develop protective antibodies following pneumococcal and influenza vaccinations when also treated with anti-TNF agents, thus reducing their risk for developing the flu and the most common type of bacterial pneumonia, accor [click link for full article]
Rheumatoid Arthritis Meds Won't Up Most Cancer Risk (HealthDay via Yahoo! News)
SUNDAY, Nov. 12 (HealthDay News) -- Biologic therapy doesn't appear to increase the overall risk of cancer, other than skin cancers, in patients with rheumatoid arthritis, according to researchers who analyzed long-term data from a U.S. national registry.
Early Aggressive Treatment May Alter Course Of Rheumatoid Arthritis (Medical News Today)
Early administration of methotrexate and infliximab may lead to remission in patients with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC. [click link for full article]
New Information About Accelerated Aging Among People With Rheumatoid Arthritis (Medical News Today)
The observation that people with rheumatoid arthritis (RA) die at a younger age than people without this disease is not new, but arthritis experts don't fully understand the causes of the increased mortality rates. Laboratory scientists have observed that RA and other diseases can cause multiple systems within the body to age more rapidly than expected. [click link for full article]
Adalimumab Proves Effective For Children With Juvenile Rheumatoid Arthritis (Medical News Today)
Adalimumab, an injectable anti-TNF therapy that has FDA approval for treating rheumatoid arthritis in adults, has proven effective in children with juvenile rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Washington, DC. [click link for full article]
(AFX UK Focus) 2006-11-13 07:57 GMT: Genentech's MabThera improves rheumatoid arthritis with repeat treatment - trial (Interactive Investor)
ZURICH (AFX) - Genentech Inc, in which Basel-based pharma group Roche Holding AG holds a majority stake, announced positive data from new trials with MabThera/Rituxan against rheumatoid arthritis (RA).
Back to Alternative Treatments for Arthritis
Back to Arthritis News Archive
|
|
|